As a result of the synovial sarcoma-associated t(X;18) translocation, the SS18 gene on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome. The SS18 protein is thought to act as a transcriptional co-activator, whereas the SSX proteins are thought to act as transcriptional corepressors. The main SSX-repression domain is located in its C terminus, a domain that is retained in the respective SS18-SSX fusion proteins. Both the SS18 and SSX proteins lack DNAbinding domains. Previously, we found that the SS18 and SS18-SSX fusion proteins may be tethered to DNA targets via the SS18-interacting protein AF10. Here, we set out to isolate proteins that interact with the SSX C-terminal repression domain using a yeast two-hybrid interaction trap. Of the positive clones isolated, two corresponded to the LIM homeobox protein LHX4, a DNA-binding protein that is involved in transcription regulation. An endogenous interaction was subsequently established in mammalian cells via colocalization and coimmunoprecipitation of the respective proteins. Interestingly, the LHX4 gene was previously found to be deregulated in various human leukemias. In addition, it was previously found that LIM homeobox proteins may bind to and activate the glycoprotein-a (CGA) promoter. Using LHX4 chromatin immunoprecipitation and CGApromoter assays, we found that endogenous LHX4 binds to the CGA promoter and that LHX4-mediated CGA activation is enhanced by the SS18-SSX protein, but not by the SSX protein. Taken together, we conclude that this novel protein -protein interaction may have direct consequences for the (de)regulation of SSX and/or SS18-SSX target genes and, thus, for the development of human synovial sarcomas.
Introduction
Synovial sarcoma is an aggressive soft tissue tumor predominantly affecting children and young adults. Cytogenetically, it is characterized by a recurring chromosomal translocation, t(X;18)(p11;q11), which is found in more than 95% of all cases (dos Santos et al., 2001; Ladanyi et al., 2002) . As a result of this translocation, the SS18 gene (previously called SYT) on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome, SSX1, SSX2 or SSX4 (Clark et al., 1994; Crew et al., 1995; de Leeuw et al., 1995; Skytting et al, 1999) . The occurrence of either SS18-SSX1 or SS18-SSX2 fusions was found to correlate to histologic (de Leeuw et al., 1994) and/or prognostic (Kawai et al., 1998; Ladanyi et al., 2002) parameters, although the latter observation could not be confirmed (Guillou et al., 2004) .
The SS18 gene is well conserved over evolution and is expressed widely in embryonic and adult tissues (de Bruijn et al., 1996; 2001b) . The human SS18 protein resides in the nucleus where it displays a distinct punctate pattern (Brett et al., 1997; dos Santos et al., 1997) . The SS18 protein is a modular protein, consisting of two functional domains, the SS18 N-terminal homology (SNH) domain and the glutamine, proline, glycine and tyrosine-rich QPGY domain (Thaete et al., 1999; de Bruijn et al., 2001a) . Of these, the SNH domain directly interacts with the acute leukemia-associated transcription factor AF10 (de Bruijn et al., 2001a) , the SWI/SNF ATPases BRM and BRG1 (Thaete et al., 1999; Perani et al., 2003; de Bruijn et al., 2006) , the histone acetyltransferase p300 (Eid et al., 2000) and the corepressor mSin3A (Ito et al., 2004) . Indirectly, the SS18 protein associates with yet another SWI/SNF protein, INI1 (Debernardi et al., 2002; Kato et al., 2002) . The QPGY domain is a transcriptional coactivation domain and mediates multimerization of the SS18 protein (Brett et al., 1997; Thaete et al., 1999; Perani et al., 2003) . Together, these findings indicate that the SS18 protein acts as transcriptional co-activator through chromatin modification mechanisms (de Bruijn et al., 2006) .
The SSX genes constitute a family of at least nine members which are located in two clusters on the X chromosome Gure et al., 1997; dos Santos et al., 2000b) . All SSX genes encode proteins of 188 amino acids, which are rich in charged amino acids and contain an acidic C-terminal tail. Normal SSX expression has been found in testis and, at a low level, in thyroid (Crew et al., 1995; Gure et al., 1997 Gure et al., , 2002 . Ectopic SSX expression has been observed in various tumor types, in particular in human melanomas (Tureci et al., 1998 (Tureci et al., , 1996 dos Santos et al., 2000b) . Homology between the SSX family members is high, ranging from 88 to 95% at the protein level. The SSX proteins were found to repress transcription in reporter assays (Brett et al., 1997; Thaete et al., 1999) . Part of this activity was mediated by the N-terminal SSX moiety that exhibits homology to the family of Kru¨ppel-associated box (KRAB) repression domains, which were recently associated with heterochromatin (Huntley et al., 2006; Vogel et al., 2006) . However, considerably stronger repression was achieved by the SSX C-terminal 34 amino acids, which was therefore designated SSX-repression domain (SSXRD; Figure 1 ). This acidic domain (pI 4.8) does not display obvious homologies to known protein domains, but exhibits a high degree of similarity between the various SSX family members (Lim et al., 1998; dos Santos et al., 2000a) . Immediately upstream of the SSXRD, a divergent domain (DD) has been defined that exhibits the highest degree of divergence between the various SSX family members (dos Santos et al., 2000a) . Although there is no evidence to suggest that the SSX proteins can bind DNA directly, all SSX proteins are localized in the nucleus, being both diffusely distributed and concentrated in nuclear dots (Brett et al., 1997; dos Santos et al., 1997 dos Santos et al., , 2000a Soulez et al., 1999) . These dots have been found to also harbor several members of the polycomb group (PcG) proteins, that is, HPC2, BMI1 and RING1 (Lim et al., 1998; dos Santos et al., 2000a) . In line with the transcriptional repressor function(s) of the SSX proteins, PcG proteins form multi-protein complexes that maintain the repressed state of target genes by inducing changes in chromatin structure (Schuettengruber et al., 2007; Schwartz and Pirrotta, 2007) . Through cellular colocalization studies, we and others have found that the SSXRD is responsible for (i) SSX nuclear localization, (ii) colocalization with PcG proteins, (iii) association with mitotic chromosomes, and (iv) association with core histones (dos Santos et al., 2000a; Kato et al., 2002) . Through yeast two-hybrid screening, we have previously identified the SSX2IP (also known as ADIP) and RAB3IP proteins as in vivo interactors of the SSX KRAB-like domain . Since no direct interactions between SSX and any of the PcG proteins have been demonstrated, we assume that other proteins mediate the observed associations between SSX and PcG proteins. Taken together, these data suggest that the SSX proteins function as transcriptional corepressors, and exert these functions through interactions with, as yet, unknown DNA-binding proteins.
In the majority of SS18-SSX fusion proteins characterized to date, the C-terminal eight amino acids of the SS18 protein are replaced by the C-terminal 78 amino acids of one of the SSX proteins (Clark et al., 1994; Crew et al., 1995; de Leeuw et al., 1995) . As a consequence, the SS18 QPGY domain is interrupted and the complete KRAB domain of SSX is lost. The main body of the SS18 protein, including the SNH domain, is fused to the highly polar C-terminal SSX tail, including the SSX-divergent (SXXDDs) and SSXRDs. This fusion has been associated with neoplastic transformation (Nagai et al., 2001 ) and changes in the epigenetic makeup of target genes (de Bruijn et al., 2006) . Another recent study indicated that the SS18-SSX1 and SS18-SSX2 fusion proteins interact preferentially with the transcription factors Snail and Slug, respectively (Saito et al., 2006) . These interactions were shown to be specific for the fusion proteins and might provide an explanation for the (disputed) correlation between fusion type and histologic appearance (Guillou et al., 2004) . Here, we have searched for interacting proteins through yeast two-hybrid screening using the SSX1 C-terminal domains DD and SSXRD as a bait. Our The SSX C terminus interacts with LHX4 DRH de Bruijn et al data indicate that the C terminus of the SSX1, SSX2 and SSX4 proteins interact in vivo with the LIM homeobox protein LHX4. This transcription factor was previously found to be deregulated and/or translocated in chronic and acute leukemias (Wu et al., 1996; Dong et al., 1997; Wu and Minden, 1997; Kawamata et al., 2002; Yamaguchi et al., 2003) . The putative implications of these novel protein -protein interactions for the development of human synovial sarcomas and other SSX-positive tumors are discussed.
Results
The SSX1, 2 and 4 C termini interact with LHX4 To search for novel SSX interactors, we used a testis cDNA interaction library for a yeast two-hybrid screen as described before (de Bruijn et al., , 2001a . For this screen, we cloned a SSX1 C-terminal fragment (SSX1CT), encompassing amino acids 96-188 of the SSX1 protein and including the SSXDD and SSXRD (Figure 1a ), into a pBD-GAL4 vector (de Bruijn et al., 2001a) . Transformation of this SSX1CT bait alone in yeast cells did not yield any growth on histidine-deficient plates, indicating that this SSX1 fragment does not contain any activation domains. Next, this bait was cotransfected with the cDNA interaction library and approximately 1 Â 10 6 Leu þ /Trp þ -independent yeast transformants were generated. Replating of these transformants on histidine-deficient plates yielded 30 Leu þ /Trp þ /His þ clones, which were selected for further analysis. Sequencing revealed that five of these clones contained two independent, but clonally expanded, cDNAs corresponding to the human LHX4 gene (preys 3 and 4; Figure 1a) . Retransformation of the SSX1CT bait together with these prey cDNAs confirmed the yeast two-hybrid interaction. Cotransfection of each prey with two control plasmids expressing lamin-B and p53 turned out negative, thereby validating the yeast two-hybrid interaction observed. The LHX4 gene encodes a 390 amino-acid protein with two tandem LIM domains (LIM1 and LIM2), followed by a single homeodomain (HOX) and a C terminus without apparent functional domains (Figure 1 ). This member of the LIM homeobox protein family was found to be critical for pituitary and motor neuron development (Sheng et al., 1997; Sharma et al., 1998) . Further sequence analysis revealed that both prey cDNAs carried the LHX4 poly-A tail and started at nucleotide 685 (prey 3; amino acid 155) and 622 (prey 4; amino acid 134) of the published LHX4 sequence, respectively. The deduced proteins encompassed the HOX and the uncharted LHX4 C terminus ( Figure 1a ). To test whether the SSX/LHX4 interaction is specific for the SSX1-derived C terminus, we cloned the corresponding C termini of the SSX2 and SSX4 genes into the pBD-GAL4 vector and tested them for interaction with LHX4 prey 3 in the yeast two-hybrid system. Using this assay, we found that all three SSX C-terminal domains were equally able to interact with LHX4, indicating that this interaction is a general feature of all three SSX proteins (not shown).
To determine whether the uncharted LHX4 C terminus harbors transcriptional repression and/or activation capacities, we set out to perform another yeast two-hybrid screen, this time using two LHX4 fragments as baits (Figure 1b ; baits 1 and 2). Both fragments were cloned into the pBD-GAL4 vector, introduced into yeast strain pJ69-4A, and assayed for auto-activation of the His reporter gene mediated by the LHX4 baits alone. By doing so, we found that all clones in which the LHX4 C terminus was fused to the GAL4 DNA-binding domain sustained growth on histidinedeficient plates, indicating that the LHX4 C terminus indeed harbors a novel transcriptional activation domain ( Figure 1b ).
SSX1 and LHX4 colocalize in transfected cells
For a further validation of the SSX/LHX4 interaction, we determined the sub-cellular (co)localization of both proteins. Therefore, full-length SSX1 and LHX4 cDNAs were cloned in-frame with the cyan and yellow fluorescent proteins ECFP and EYFP, respectively, and cotransfected into HeLa cells. After fixation, the transfected cells were analysed for fluorescent signals, using 4 0 ,6-diamidino-2-phenylindole as a nuclear counter stain. In the majority of EYFP-SSX1/ECFP-LHX4 double-transfected cells, we observed EYFP-SSX1 signals as nuclear dots combined with a diffuse nuclear staining (Figures 2b and f; green). In addition, we observed that the size and number of dots varied per cell, ranging from 2 to B50 dots. These observations are completely in line with previously published data (dos Santos et al., 2000a) . In all double-transfected cells, the ECFP-LHX4 signals displayed a similar nuclear pattern, although with a somewhat lower intensity, with a clear absence of nucleolar staining (Figures 2c and g; red) . In the overlay of the green and red images, almost all signals were yellow (Figures 2d and h), indicating a near complete colocalization of the SSX1 and LHX4 proteins, particularly in the nuclear dots. In a low percentage of double-transfected cells, a configuration of many small nuclear SSX and LHX4 dots could be observed (Figures 2j and k) . The overlay of these images clearly indicated that colocalization in such nuclei was incomplete (Figures 2j-l; arrowheads) . Similar experiments using ECFP-EYFP dye-swaps, transfection of COS1 cells and/or expression of fluorescently tagged SSX1CT proteins yielded very similar results (not shown). We conclude that the exogenously expressed SSX1 and LHX4 proteins colocalize in both HeLa and COS1 cell nuclei. In a small percentage of, morphologically distinct, nuclei this colocalization was incomplete, indicating that the SSX/LHX4 interactions may be dynamic in nature.
SS18-SSX1 and LHX4 colocalize in nuclear domains
Next, we tested whether the SS18-SSX1 fusion protein also colocalizes with LHX4. Therefore, a full-length SS18-SSX1 cDNA was cloned in-frame with the cyan The SSX C terminus interacts with LHX4 DRH de Bruijn et al fluorescent protein (ECFP) and combined with the same EYFP-LHX4 construct that was used previously (see above). These constructs were either transfected into the HeLa cell line or into the synovial sarcoma cell line SYO1 (Kawai et al., 2004) , and the fluorescent signals were analysed using confocal laser scanning microscopy. Previously, we identified the AF10 protein as a bona fide interactor of the SS18 N terminus (de Bruijn et al., 2001a) . Since the AF10 interacting domain is retained in the SS18-SSX fusion protein, we included an AF10 expression construct encoding the full-length AF10 protein fused to dsRED in our SYO1 cotransfection experiments. By doing so, we observed that all triple labeled cells displayed nuclear EYFP, ECFP and dsRED signals (Figure 3 ; green, blue and red, respectively). Most of the nuclei exhibited an almost full colocalization of all three proteins (Figure 3 ; top row), while some showed less colocalization (Figure 3 ; bottom row). However, since we did not find any cells in which the LHX4 and AF10 proteins colocalized without SS18-SSX1 staining, the presence of this fusion protein appears to be crucial for the colocalization of LHX4 and AF10 in the same nuclear domains. The cotransfections of HeLa cells yielded very similar results (not shown).
Coimmunoprecipitation of endogenous LHX4 and SS18-SSX proteins
To establish a direct interaction between the SSX1 and LHX4 proteins, we performed immunoprecipitations from HeLa cells, which were transfected with full-length SSX1 and LHX4 expression constructs. In this fashion, we readily detected the LHX4 protein in anti-SSX immunoprecipitates (not shown), indicating that the exogenous SSX1 and LHX4 proteins interact directly. To confirm this interaction in vivo within the context of synovial sarcoma, we set out to coimmunoprecipitate Figure 2 Detection of EYFP-SSX1 (b, f and j; green) and ECFP-LHX4 full-length (c, g and k; red) in double-transfected HeLa cells. After overlay of these images an almost complete colocalization can be observed for EYFP-SSX1 and ECFP-LHX4 (d, h and l; yellow). 4 0 ,6-Diamidino-2-phenylindole (DAPI) counterstaining indicates a nuclear localization of all signals (a, e and i; blue). In morphologically distinct nuclei displaying numerous fine dots (i-l), partial loss of SSX1/LHX4 colocalization can be observed (j-l; arrowheads).
The SSX C terminus interacts with LHX4 DRH de Bruijn et al the endogenous LHX4 and SS18-SSX (fusion) proteins. Since we did not observe any preference of SSX C termini for interaction with the LHX4 protein (see above), we again employed the synovial sarcoma cell line SYO1, which expresses the SS18-SSX2 and LHX4 proteins endogenously, but does not express wild-type SSX, as judged by western blotting and reverse transcription (RT)-PCR (not shown). SYO1 nuclear extracts were subjected to immunoprecipitation with a rabbit pre-immune serum (mock IP) and a rabbit polyclonal anti-SSX antibody (B39; dos Santos et al., 1997) , which recognizes the SS18-SSX2 fusion protein.
The input material and both immunoprecipitates were analysed by western blotting using a polyclonal goat anti-LHX4 antibody. In the nuclear extract (NE) and in the anti-SSX immunoprecipitate (SS18-SSX2 IP), but not in the mock IP, the endogenous LHX4 protein was observed as a doublet of two bands (50 and 48 kDa, Figure 4a ). Similarly, we performed immunoprecipitations with the anti-LHX4 antibody. After western blotting using the anti-SSX antibody, the endogenous 55 kDa SS18-SSX2 protein could readily be observed in the nuclear extract (NE) and the anti-LHX4 immunoprecipitate (LHX4 IP), but not in the mock IP (Figure 4b ). From these results, we conclude that the endogenous LHX4 and SS18-SSX2 (fusion) proteins interact in vivo. In synovial sarcoma cells, this interaction may confer the transcriptional regulatory functions of the SS18-SSX fusion proteins to cognate LHX4 target genes.
SSX and SS18-SSX affect LHX4-mediated gene expression To establish whether the SSX and/or SS18-SSX (fusion) proteins are able to affect the expression of known LHX target genes, we performed both chromatin immunoprecipitation (ChIP) and transactivation assays. A known target of other LHX proteins is the glycoprotein hormone-a (CGA) gene. LHX-mediated CGA gene expression depends on the presence of a LHX-binding site (PGBE) within the CGA promoter (Roberson et al., 1994) . To establish direct binding of the LHX4 protein to this promoter, we performed ChIP with the anti-LHX4 antibody on SYO1 extracts. The recovered ChIP DNAs were analysed by real-time quantitative PCR (Q-PCR) for enrichment of CGA-promoter sequences. By doing so, we obtained a P/I value (see Materials and methods) of 6.18 (mean of three independent experiments), indicating that in SYO1 cells the endogenous LHX4 protein binds to the CGA promoter. To subsequently determine the effect of the SS18-SSX2 and/or SSX2 proteins on CGA expression, we cloned two CGA-promoter fragments into a pGL3 luciferase reporter construct. Of these fragments, one lacked the LHX-binding site PGBE (CGA1) whereas the other contained this site (CGA2; Figure 4c ). Together with a Renilla luciferase control plasmid, these CGA constructs were transfected into SYO1 cells. Subsequently, the luciferase activities were measured, and normalized to the Renilla values. To assess the effect of the LHX4-binding site on CGA-promoter activation, the CGA2 values were normalized to the CGA1 values. In three independent transfection experiments (each measured in duplicate), we observed a threefold increase in luciferase activity in the CGA2-transfected SYO1 cells as compared to the CGA1-transfected SYO1 cells (data not shown). In similar experiments, using an SS18-SSXnegative, LHX4-positive cell line (HEK293), we observed a twofold increase of CGA2-promoter activity versus CGA1-promoter activity. These results indicate that the SS18-SSX2 protein, in conjunction with the LHX4 protein bound to the LHX4-binding site, significantly enhances CGA transactivation. To assess further whether the wild-type SSX protein affects this SS18-SSX2-mediated CGA transactivation, we included Figure 3 Confocal images of two triple-transfected SYO1 cells. From left to right: triple image overlay, EYFP-LHX4, ECFP-SS18-SSX1 and dsRED-AF10. In the upper nucleus, an almost complete colocalization of ECFP-SS18-SSX1, EYFP-LHX4 and dsRED-AF10 signals (nearly white in the overlay) can be observed in a nuclear dotted pattern. The lower nucleus displays regions with more prominent SS18-SSX1-AF10 colocalization (light purple in the overlay), alternating with domains displaying full colocalization (white in the overlay).
The SSX C terminus interacts with LHX4 DRH de Bruijn et al an SSX2 expression vector (and a control empty vector) in the same transfection experiments and determined the luciferase activities as described above. In the control empty vector experiments, again an approximately threefold increase in luciferase activity was observed in CGA2-transfected versus CGA1-transfected SYO1 cells (Figure 4d ; vector). However, this effect was significantly decreased upon exogenous SSX2 expression (Figure 4d ; SSX2), indicating that the SSX2 protein exerts an inhibitory effect on the SS18-SSX2/LHX4-mediated CGA transactivation. These data indicate that, in the context of synovial sarcoma, the SSX2 and SS18-SSX2 proteins exert opposite regulatory activities, probably by competing for binding to the LHX4 protein.
Discussion
Through yeast two-hybrid screening, using the synovial sarcoma-associated SSX1 C terminus as a bait, we isolated two cDNAs corresponding to the LHX4 protein, a transcription factor that is known to be involved in pituitary and motor neuron development (Sheng et al., 1997; Sharma et al., 1998; Machinis et al., 2001; Raetzman et al., 2002) and to be deregulated and/ or translocated in human chronic myeloid and acute lymphoblastic leukemias (Wu et al., 1996; Dong et al., 1997; Wu and Minden, 1997; Kawamata et al., 2002; Yamaguchi et al., 2003) . In the yeast two-hybrid system, the LHX4 protein interacts equally well with the C terminus of all SSX proteins known to be involved in synovial sarcoma, that is SSX1, SSX2 and SSX4. We validated this interaction in synovial sarcoma cells via coimmunoprecipitation of the respective endogenous (fusion) proteins. Further support that LHX4 is a bona fide interactor of the SSX proteins came from cellular colocalization experiments, which were in conformity with our previously published data (dos Santos et al., 2000a) . This colocalization, however, was not always complete, indicating that the SSX/LHX4 interaction may be dynamic in nature. Whereas most cells showed up to B50 nuclear dots in otherwise diffusely stained nuclei with an almost complete SSX/LHX4 colocalization, some cells showed a configuration of many relatively small nuclear dots with an incomplete SSX/ LHX4 colocalization. A similar, but less obvious, pattern of incomplete colocalization was observed in some triple (SS18-SSX1, LHX4 and AF10)-transfected cells, indicating that the dynamic regulation may also relate to the SS18-SSX fusion proteins. The exact mechanisms underlying these dynamic protein localization patterns still remain to be identified. The LHX4 protein exhibits features typical of transcription factors, including a DNA-binding HOX and two tandem LIM domains, each containing two zinc fingers. LIM HOX protein genes have frequently been found to be involved in cancer. Ectopic expression of the LHX1 and LHX2 genes has, for example, been detected in various leukemias (Wu et al., 1996; Dong et al., 1997; Wu and Minden, 1997) and stable expression of the LHX2 gene in hematopoietic stem cells, engrafted in stem cell-deficient mice, has been shown to cause myeloproliferative disorders and acute leukemias (Richter et al., 2003) . In cellular transformation assays, using Rat1 and NIH3T3 cell lines, the oncogenic activities of the LHX4 gene could not be defined (Kawamata et al., 2002) , but aberrant expression of this gene was observed in the case of chronic myeloid leukemia in blast crisis and in the case of pre-B acute lymphoblastic leukemia. Both cases carried a t(1;14)(q25;q32) chromosome translocation, which The SSX C terminus interacts with LHX4 DRH de Bruijn et al resulted in juxtaposition of the respective LHX4 and IGH genes (Kawamata et al., 2002; Yamaguchi et al., 2003) . The LHX4 gene was also found to be overexpressed in the pre-B acute lymphoblastic leukemia cell line MD930 (Yamaguchi et al., 2003) . During normal development, the LHX4 gene is predominantly expressed in the central nervous system (Liu et al., 2002) , and it was proposed that its overexpression may be associated with cellular proliferation and/or anti-apoptosis (Kawamata et al., 2002; Yamaguchi et al., 2003) . Indeed, mouse knockout studies revealed that LHX4 deficiency leads to an increased apoptotic rate in Rathke's pouch, resulting in an impaired pituitary development reminiscent of human congenital pituitary hormone deficiency (CPHD; Sheng et al., 1997; Machinis et al., 2001; Raetzman et al., 2002) . In addition, LHX4 was shown to have a direct stimulatory effect on for example the prolactin gene promoter. This activation could be enhanced by other HOX-containing transcription factors such as Pit-1, or be inhibited by interacting proteins such as the selective LIM-binding protein SLB (Howard and Maurer, 2000) , indicating that the modulation of LHX4 activity occurs through protein -protein interactions. In this study, we observed a similar, LHX4-mediated, regulation of the CGA gene. Through ChIP, we were able to show that endogenous LHX4 binds directly to the CGA promoter in synovial sarcoma cells. Furthermore, we found through promoter assays that the regulation of CGA gene expression is differentially affected by the LHX4-interacting proteins SSX and SS18-SSX, that is, the CGA promoter was activated in the presence of the SS18-SSX fusion protein, but repressed upon exogenous expression of the wild-type SSX protein. Therefore, we assume that this novel SSX/ LHX4 interaction may act as an allosteric mechanism (Howard and Maurer, 2000) to regulate LHX4-and/or SSX-associated functions. In synovial sarcoma cells, this mechanism may be affected by the SS18-SSX fusion protein, thereby, inhibiting apoptosis and/or promoting proliferation. Endogenous LHX4 (over)expression has been found to inhibit apoptosis in leukemias, while endogenous, ectopic (over)expression of wild-type SSX genes has been observed in melanoma (dos Santos et al., 2001) , osteosarcoma (Naka et al., 2002) , breast cancer (Mischo et al., 2006) and multiple myeloma (Taylor et al., 2005) . Although the significance of SSX (over)-expression in these tumor types has not yet been addressed, one study has indicated that it may affect cell motility (Cronwright et al., 2005) . Obviously, further studies are required to assess whether and to what extent the LHX4 and SSX genes are coexpressed in these (and other) tumor types. Our current work, and that of others, indicates that the SSX C terminus is involved in multiple functions, including histone association, transcriptional repression (possibly mediated by the polycomb complex) and LHX4 protein interaction. The regulation of one or more of these functions may occur in a competitive and dynamic fashion. As such, interaction with the LHX4 protein might be sufficient for SSX proteins to render their repression domains (SSXRD) inactive and/or dissociate them from their polycomb link. A preliminary indication for the existence of such a dynamic interaction comes from our observations that in a certain percentage of the nuclei studied, the SSX1/LHX4 and SS18-SSX1/LHX4 interactions are incomplete.
Taken together, we have shown that the C-terminal domain of the SSX protein interacts in vivo with the LIM HOX protein LHX4 and that, through this interaction, the SSX protein may exert one or more of its multiple functions, including that of a transcriptional corepressor. Previously, we found that the Nterminal domain of the SS18 protein interacts with the transcription factor AF10 and that, through this interaction, the SS18 protein may exert its function as a transcriptional co-activator (de Bruijn et al, 2001a) . In Figure 5 , the consequences of these and other protein -protein interactions are depicted for normal and t(X;18)-positive synovial sarcoma cells, in which the SS18-SSX fusion protein is thought to act as a transcriptional 'activator -repressor'. This anomalous regulatory function is expected to lead to an aberrant regulation of target genes and, ultimately, malignant transformation.
Materials and methods

Cloning and sequencing procedures
All cloning procedures were essentially as described before (de Bruijn et al., 1996; 2001a, b) . Sequence analyses were performed at the DNA Sequence Facility of the Radboud University Nijmegen Medical Centre. DNA and protein databases were searched using the BLAST or BLAT search algorithms at the NCBI or UCSC, respectively. The SSX1, SSX2 and SSX4 bait fragments, carrying amino acids 96-188 of either protein, were generated by PCR from full-length cDNAs and cloned in frame with the GAL4 DNA-binding domain into the pBD-GAL4-Cam vector (Stratagene, La Jolla, CA, USA). For efficient, in-frame cloning of selected interactors (and deletion fragments thereof) with the GAL4 transactivation or DNA-binding domains, we used the same set of adapted pGAD10 (Clontech, Mountain View, CA, USA) and pBD-GAL4-Cam vectors as described previously (de Bruijn et al., 2001a) . All SSX1 and LHX4-deletion fragments were generated by PCR with specific oligonucleotide primers. PCR products were sub-cloned into pGEM-T (Promega, Leiden, The Netherlands) and, after verification by sequencing, cloned into the correct yeast or mammalian expression vector.
Yeast two-hybrid screening Yeast two-hybrid screening was performed using a human testis cDNA library . For the construction of this library, poly-A( þ ) RNA was isolated using OLIGOTEX (Qiagen, Venlo, The Netherlands), reversetranscribed and cloned into hybriZAP (Stratagene). The resulting primary phage library contained 4 Â 10 6 independent clones. Approximately 1 Â 10 6 clones were amplified once and 1 Â 10 9 of the resulting plaque forming units were mass-excised according to manufacturers' instructions to generate the interaction cDNA library in pAD-GAL4. The average insert size of this library was estimated to be around 1 kb. The yeast strain used for all interaction traps was pJ69-4A (a kind gift from Philip James). Positive interactions in this yeast strain
The SSX C terminus interacts with LHX4 DRH de Bruijn et al can be selected for by adenine and histidine auxotrophy, next to b-galactosidase activity. This yeast strain was cotransformed with the bait plasmid pBD-GAL4-SSX1CT and the testis cDNA library (in pAD-GAL4), using the Yeastmaker transformation kit (Clontech). Subsequently, all double transfectants, containing a pBD and a pAD vector, were selected on selective medium lacking leucine and tryptophan. A total of 1 Â 10 6 double transformants were harvested and replated on selective medium lacking leucine, tryptophan and histidine, supplemented with 25 mM of 3-aminotriazole (3-AT; Sigma, Zwijndrecht, The Netherlands). LacZ activity was determined for all growing colonies using a filter lift assay according to the manufacturers' instructions. The cDNA inserts of positive clones were isolated by direct PCR on yeast colonies with two pAD-GAL4 specific oligonucleotides, ADfor (CTGTCACCTGGTTGGACGGACCAA) and pGADrev (GTGAACTTGCGGGGTTTTTCAG). After sequencing of the PCR products, the pAD plasmids from the yeast interaction clones were rescued in DH5a bacteria. The interacting cDNA clones were retransformed together with the standard control plasmids expressing lamin-B and p53 and the SSX1 bait into pJ69-4A to confirm the previously found interaction.
Transfections, fluorescence and immunoprecipitation assays Human HeLa, green monkey kidney COS1 and human synovial sarcoma SYO1 cells were grown in Dulbecco's modification of Eagle's medium containing 10% fetal calf serum. Transient transfections of these cell lines were performed with the Amaxa Nucleofector in Amaxa buffer V with program A28 (HeLa and COS1) or O17 (SYO1). Approximately 1 mg of each of the appropriate plasmid DNAs, pECFP-SSX1/pEYFP-SSX1, pEYFP-LHX4/pECFP-LHX4 and/or pdsRED-AF10 were combined with 3 Â 10 6 cells in each transfection. The transfected cells were seeded on poly-Llysine (Sigma)-coated glass slides and grown for another 16-18 h, before fluorescent analysis. Fluorescent detection of the transfected ECFP, EYFP and dsRED-tagged proteins was performed after a 30 min fixation in 3% formaldehyde as described previously (de Bruijn et al., 2001a . For the endogenous SS18-SSX2/LHX4 coimmunoprecipitations, nuclear extracts were prepared from SYO1 cells according to the Lamond Lab protocol (http://www.lamondlab.com/f7pro-tocols.htm). Approximately 500 mg of freshly prepared nuclear proteins were subjected to immunoprecipitations with 2 mg of the goat anti-LHX4 antibody (sc-22136, Santa Cruz, Heidelberg, Germany), the affinity-purified B39 rabbit anti-SSX antibody, and the goat and rabbit pre-immune sera in the presence of protein A/G agarose beads (Santa Cruz). After washing, the whole immunoprecipitates, the corresponding mock-IP, and 50 mg of nuclear extract, were used to prepare western blots according to standard procedures. These blots were incubated with either the anti-SSX (LHX4-IP) or the anti-LHX4 (SSX-IP) antibodies. The signals were detected with the Odyssey Infrared Imaging System (LI-COR, Lincoln, NE, USA), using the Alexa Fluor 680 goat anti-rabbit IgG (Molecular probes, Leiden, The Netherlands) or IRDye-800 donkey anti-Goat IgG (Rockland, Gilbertsville, PA, USA) as secondary antibodies.
Chromatin immunoprecipitations and CGA transactivation assays Chromatin was extracted from SYO1 cells as described (Boyd et al., 1998) . Protein -DNA complexes were immunoprecipitated with a LHX4 antibody (see above) and a goat preimmune serum. The recovered genomic DNAs were analysed by Q-PCR on an ABI 7700 sequence detection system, using a SYBR green PCR master mix (Applied Biosystems, Nieuwerkerk a/d ijssel, The Netherlands) with primer pairs spanning the CGA promoter (F: GTACAAAGTGACAGCGTA CTCTCTTTTCATG; R: AGCTTCGTCTTATGAGTTCTC AGTAACTG), and an intronic region located 1.6 kb downstream (F: GTTACAGCAGTGCCATTGTAATGTTGC; R: CTGATGCTAAGATGGTGTCCTTCCAC). The Q-PCR data were calculated as promoter/intron ratios (P/I) to indicate the enrichment of the CGA-promoter sequence in the LHX4 ChIP. For the transactivation experiments, two CGA-promoter fragments (CGA1: À253 to þ 50 and CGA2: À752 to Figure 5 Model depicting the synovial sarcoma-associated SS18, SSX and SS18-SSX (fusion) proteins and their respective (dynamic) interactions. In normal cells (left), the SSX proteins and their interactors SSX2IP and RAB3IP may associate with the polycomb complex and histones and in addition, through interaction with the LHX4 protein, bind to cognate DNA sites and affect target gene expression. The SS18 protein and its interacting proteins BRM, BRG1, Sin3A and p300 may associate with the SWI/SNF complex and in addition, through interaction with the AF10 protein, bind to cognate DNA sites and affect target gene expression. In synovial sarcoma cells (right), the SS18-SSX fusion proteins have lost the interaction domains for SSX2IP and RAB3IP, but have retained the interaction/association domains for both the SWI/SNF and the polycomb complexes. Through these interactions, the SS18-SSX fusion proteins may anomalously affect the regulation of these target genes and/or affect the regulation of other (novel) target genes, either through AF10, LHX4 or both.
The SSX C terminus interacts with LHX4 DRH de Bruijn et al þ 50) were generated by PCR and cloned into the pGL3 luciferase-reporter vector (Clontech). These vectors were cotransfected in triplicate with a Renilla luciferase expression vector (Promega) into the SYO1 cell line and seeded in duplicate. One day after transfection, the cells were lysed and firefly and Renilla luciferase activities were measured using the Dual-Glo Luciferase System (Promega).
